Details for Patent: 5,089,500
✉ Email this page to a colleague
Summary for Patent: 5,089,500
| Title: | Therapeutic nucleosides |
| Abstract: | The present invention relates to 6-substituted purine carbocyclic nucleosides and their use in medical therapy particularly in the treatment of HIV and HBV infections. Also provided are pharmceutical formulations and processes for the preparation of compounds according to the invention. |
| Inventor(s): | Daluge; Susan M. (Chapel Hill, NC) |
| Assignee: | Burroughs Wellcome Co. (Research Triangle Park, NC) |
| Application Number: | 07/697,260 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 5,089,500
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 5,089,500
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| United Kingdom | 8815265 | Jun 27, 1988 |
International Family Members for US Patent 5,089,500
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 0434450 | ⤷ Sign Up | SPC/GB99/032 | United Kingdom | ⤷ Sign Up |
| European Patent Office | 0434450 | ⤷ Sign Up | C990028 | Netherlands | ⤷ Sign Up |
| European Patent Office | 0434450 | ⤷ Sign Up | 33/1999 | Austria | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
